-
EP3172235
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3172235
| EP3172235 - ANTI-CD3 ANTIBODIES, ACTIVATABLE ANTI-CD3 ANTIBODIES, MULTISPECIFIC ANTI-CD3 ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTI-CD3 ANTIBODIES, AND METHODS OF USING THE SAME [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 16.03.2018 Database last updated on 10.07.2024 | |
| Former | Request for examination was made Status updated on 28.04.2017 | ||
| Former | The international publication has been made Status updated on 27.01.2017 | Most recent event Tooltip | 19.06.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states Cytomx Therapeutics Inc. 151 Oyster Point Blvd, Suite 400 South San Francisco CA 94080 / US | [2017/22] | Inventor(s) | 01 /
IRVING, Bryan Allen 108 Ware Road Woodside, California 94062 / US | 02 /
LA PORTE, Sherry Lynn 343 Oyster Point Boulevard Suite 100 South San Francisco, California 94080 / US | 03 /
SAGERT, Jason Gary 231 Laurie Meadows Road Apt. 153 San Mateo, California 94403 / US | 04 /
HOSTETTER, Daniel Robert 3909 Park Boulevard Palo Alto, California 94306 / US | 05 /
RAZO, Olivia Jennifer 6364 Mirabeau Drive Newark, California 94560 / US | 06 /
WHITE, Clayton 343 Oyster Point Boulevard Suite 100 South San Francisco, California 94080 / US | 07 /
RICHARDSON, Jennifer Hope 647 Pickering Avenue Fremont, CA 94536 / US | [2017/22] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [N/P] |
| Former [2017/22] | Cooley (UK) LLP Dashwood 69 Old Broad Street London EC2M 1QS / GB | Application number, filing date | 15745116.2 | 24.07.2015 | [2017/22] | WO2015US42053 | Priority number, date | US201462029325P | 25.07.2014 Original published format: US 201462029325 P | [2017/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2016014974 | Date: | 28.01.2016 | Language: | EN | [2016/04] | Type: | A2 Application without search report | No.: | EP3172235 | Date: | 31.05.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.01.2016 takes the place of the publication of the European patent application. | [2017/22] | Search report(s) | International search report - published on: | EP | 17.03.2016 | (Supplementary) European search report - dispatched on: | EP | 03.04.2018 | Classification | IPC: | C07K16/28, C07K16/30, A61K39/395 | [2017/22] | CPC: |
C07K16/2809 (EP,CN,US);
A61K39/395 (EP,CN,US);
A61K47/6831 (EP,US);
A61K47/6845 (EP,US);
A61K47/6849 (EP,US);
A61K47/6851 (EP,US);
A61K47/6879 (EP,US);
A61K47/6889 (EP,US);
A61P35/00 (EP);
C07K16/2863 (EP,CN,US);
C07K16/30 (EP,CN,US);
C07K2317/31 (EP,CN,US);
C07K2317/56 (EP,CN,US);
C07K2317/565 (CN,US);
C07K2317/622 (EP,CN,US);
C07K2317/64 (EP,CN,US);
C07K2317/72 (EP,CN,US);
C07K2317/73 (CN,US);
C07K2317/92 (EP,CN,US)
(-)
| C-Set: |
A61K39/395, A61K2300/00 (CN)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/22] | Title | German: | ANTI-CD3-ANTIKÖRPER, AKTIVIERBARE ANTI-CD3-ANTIKÖRPER, MULTISPEZIFISCHE ANTI-CD3-ANTIKÖRPER, MULTISPEZIFISCHE AKTIVIERBARE ANTI-CD3-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON | [2017/22] | English: | ANTI-CD3 ANTIBODIES, ACTIVATABLE ANTI-CD3 ANTIBODIES, MULTISPECIFIC ANTI-CD3 ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTI-CD3 ANTIBODIES, AND METHODS OF USING THE SAME | [2017/22] | French: | ANTICORPS ANTI-CD3, ANTICORPS ANTI-CD3 ACTIVABLES, ANTICORPS ANTI-CD3 MULTISPÉCIFIQUES, ANTICORPS ANTI-CD3 ACTIVABLES MULTISPÉCIFIQUES ET PROCÉDÉS D'UTILISATION DE CES ANTICORPS | [2017/22] | Entry into regional phase | 27.01.2017 | National basic fee paid | 27.01.2017 | Designation fee(s) paid | 27.01.2017 | Examination fee paid | Examination procedure | 27.01.2017 | Examination requested [2017/22] | 27.01.2017 | Date on which the examining division has become responsible | 13.09.2017 | Amendment by applicant (claims and/or description) | 03.04.2018 | Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M06) [2018/18] | 03.04.2018 | Despatch of a communication from the examining division (Time limit: M06) | 09.10.2018 | Reply to a communication from the examining division | 17.01.2019 | Despatch of a communication from the examining division (Time limit: M06) | 29.07.2019 | Reply to a communication from the examining division | 29.10.2019 | Despatch of a communication from the examining division (Time limit: M06) | 07.05.2020 | Reply to a communication from the examining division | 01.09.2020 | Despatch of a communication from the examining division (Time limit: M06) | 08.04.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 07.06.2021 | Reply to a communication from the examining division | 04.10.2021 | Despatch of a communication from the examining division (Time limit: M06) | 13.04.2022 | Reply to a communication from the examining division | 22.03.2023 | Despatch of a communication from the examining division (Time limit: M06) | 29.09.2023 | Reply to a communication from the examining division | 28.02.2024 | Despatch of a communication from the examining division (Time limit: M06) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 07.06.2021 | Request for further processing filed | 07.06.2021 | Full payment received (date of receipt of payment) Request granted | 21.06.2021 | Decision despatched | Fees paid | Renewal fee | 27.07.2017 | Renewal fee patent year 03 | 27.07.2018 | Renewal fee patent year 04 | 29.07.2019 | Renewal fee patent year 05 | 27.07.2020 | Renewal fee patent year 06 | 27.07.2021 | Renewal fee patent year 07 | 27.07.2022 | Renewal fee patent year 08 | 27.07.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2007042261 (MICROMET AG [DE], et al); | [X]WO2010037836 (MICROMET AG [DE], et al) |